Bruker Corp. (NASDAQ: BRKR) and Agilent Technologies Inc. (NYSE: A) announced today that Bruker and Agilent have entered into a definitive asset purchase agreement. Pursuant to this agreement, Bruker will acquire certain product lines of Varian Inc., which Agilent has committed to divest in connection with obtaining regulatory approval for Agilent''s previously announced acquisition of Varian.
The product lines to be acquired by Bruker include:
Varian''s global inductively coupled plasma mass spectrometry (ICP-MS) instruments business located in Melbourne, Australia;
Varian''s global laboratory gas chromatography (Lab GC) instruments business located in Middelburg, the Netherlands; and
Varian''s global gas chromatography triple-quadrupole mass spectrometry (GC-QQQ) instruments business located in Walnut Creek, Calif.
应助达人
赛默飞实验室产品焕新计划有奖调研！
【七月征文】不一YOUNG实验“猿”
报名开启：ICS2024第十三届光谱网络会议！
推荐收藏！盘点中药材及饮片检测解决方案
